272
Views
11
CrossRef citations to date
0
Altmetric
Review

Treatment of chikungunya musculoskeletal disorders: a systematic review

, , , , ORCID Icon, , & show all
Pages 333-344 | Received 03 Jan 2018, Accepted 07 Mar 2018, Published online: 14 Mar 2018

References

  • Burt FJ, Rolph MS, Rulli NE, et al. Chikungunya: a re-emerging virus. Lancet. 2012;379(9816):662–671.
  • Tsetsarkin KA, Vanlandingham DL, McGee CE, et al. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3(12):e201.
  • Tsetsarkin KA, Weaver SC. Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog. 2011;7(12):e1002412.
  • Waggoner JJ, Pinsky BA. How great is the threat of chikungunya virus? Expert Rev Anti Infect Ther. 2015;13(3):291–293.
  • Cunha RVD, Trinta KS. Chikungunya virus: clinical aspects and treatment - A review. Mem Inst Oswaldo Cruz. 2017;112(8):523–531.
  • Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Febre de chikungunya: manejo clínico/Ministério da Saúde, Secretaria de Vigilância em Saúde, Secretaria de Atenção Básica. 1 ed. Brasília: Ministério da Saúde; 2015. 28. [acesso em 2016 de fevereiro de 26] Disponível em: http://bvsms.saude.gov.br/bvs/publicacoes/febre_chikungunya_manejo_clinico.pdf
  • Chopra A, Anuradha V, Ghorpade R, et al. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect. 2012;140(5):842–850.
  • Sissoko D, Malvy D, Ezzedine K, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3(3):e389.
  • Gerardin P, Fianu A, Michault A, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15(1):R9.
  • Couturier E, Guillemin F, Mura M, et al. Impaired quality of life after chikungunya virus infection: a 2-year follow-up study. Rheumatology (Oxford). 2012;51(7):1315–1322.
  • Abdelnabi R, Neyts J, Delang L. Antiviral strategies against chikungunya virus. Methods Mol Biol. 2016;1426:243–253.
  • Ravindran V, Alias G. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol. 2017;36(6):1335–1340.
  • Padmakumar B, Jayan JB, Menon RMR, et al. Comparative evaluation of four therapeutic regimes in Chikungunya arthritis: A prospective randomized parallel-group study. Indian J Rheumatol. 2009;4(3):94–101.
  • Chopra A, Saluja M, Venugopalan A. Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol. 2014;66(2):319–326.
  • Bouquillard E, Combe B. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine. 2009;76(6):654–657.
  • Ganu MA, Ganu AS. Post-chikungunya chronic arthritis–our experience with DMARDs over two year follow up. J Assoc Physicians India. 2011;59:83–86.
  • Javelle E, Ribera A, Degasne I, et al. Specific management of post-chikungunya rheumatic disorders: A retrospective study of 159 cases in Reunion Island from 2006-2012. PLoS Negl Trop Dis. 2015;9(3):e0003603.
  • Pandya S. Methotrexate and hydroxychloroquine combination therapy in chronicchikungunya arthritis: A 16 week study. Indian J Rheumatol. 2008;3(3):93–97.
  • Blettery M, Brunier L, Polomat K, et al. Management of chronic post-chikungunya rheumatic disease: the Martinican experience. Arthritis Rheumatol. 2016;68(11):2817–2824.
  • Delogu I, De Lamballerie X. Chikungunya disease and chloroquine treatment. J Med Virol. 2011;83(6):1058–1059.
  • Arroyo-Avila M, Vila LM. Rheumatic manifestations in patients with chikungunya infection. P R Health Sci J. 2015;34(2):71–77.
  • Rodriguez-Morales AJ, Cardona-Ospina JA, Fernanda Urbano-Garzon S, et al. Prevalence of post-chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2016;68(12):1849–1858.
  • Alvarez MF, Bolivar-Mejia A, Rodriguez-Morales AJ, et al. Cardiovascular involvement and manifestations of systemic Chikungunya virus infection: A systematic review. F1000Res. 2017;6:390.
  • van Aalst M, Nelen CM, Goorhuis A, et al. Long-term sequelae of chikungunya virus disease: A systematic review. Travel Med Infect Dis. 2017 Jan–Feb;15:8–22.
  • Marimoutou C, Ferraro J, Javelle E, et al. Chikungunya infection: self-reported rheumatic morbidity and impaired quality of life persist 6 years later. Clin Microbiol Infect. 2015 Jul;21(7):688–693.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–716.
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011 [cited 2017 Dec 7] Available from: handbook.cochrane.org
  • Simon F, Parola P, Grandadam M, et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine. 2007;86(3):123–137.
  • Lui NL, Leong HN, Thumboo J. Polyarthritis in four patients with chikungunya arthritis. Singapore Med J. 2012;53(4):241–243.
  • Rivera-Avila RC. [Chikungunya fever in Mexico: confirmed case and notes on the epidemiologic response]. Salud Publica Mex. 2014;56(4):402–404.
  • Peper SM, Monson BJ, Van Schooneveld T, et al. That which bends up: a case report and literature review of chikungunya virus. J Gen Intern Med. 2016;31(5):576–581.
  • Richi Alberti P, Steiner M, Illera Martin O, et al. Imported chikungunya fever in Madrid. Reumatol Clin. 2016;12(4):226–227.
  • Malvy D, Ezzedine K, Mamani-Matsuda M, et al. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis. 2009;9:200.
  • Ravichandran R, Manian M. Ribavirin therapy for Chikungunya arthritis. J Infect Dev Ctries. 2008;2(2):140–142.
  • Redel H. A case of chikungunya virus induced arthralgia responsive to colchicine. Open Forum Infect Dis. 2016;3(2):ofw114.
  • de Andrade DC, Jean S, Clavelou P, et al. Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness. BMC Infect Dis. 2010;10:31.
  • WHOCC - ATC/DDD INDEX. Who. 2017 [cited 2017 Nov 20]. Available from: https://www.whocc.no/atc_ddd_index/
  • Pan American Health Organization, World Health Organization. Number of reported cases of chikungunya fever in the Americas, by country or territory 2014-2017 (to week noted). 2015 [cited 2017 Dec 28]. Available from: http://www.paho.org/hq/index.php?Itemid=40931
  • Javelle E, Gautret P, Ribèra A, et al. The challenge of chronic chikungunya. Travel Med Infect Dis. 2017;15:3–4.
  • Centers for Disease Control and Prevention. Geographic distribution Chikungunya virus. 2016 [Cited 2017 Dec 28]. Available from: https://www.cdc.gov/chikungunya/geo/index.html
  • Boers M, Jr K, Wells G, et al. Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J Clin Epidemiol. 2014 Jul;67(7):745–753.
  • Simon F, Javelle E, Cabie A, et al. French guidelines for the management of chikungunya (acute and persistent presentations). November 2014. Med Mal Infect. 2015 Jul;45(7):243–263.
  • Marques CDL, Duarte A, Ranzolin A, et al. Recommendations of the Brazilian Society of Rheumatology for the diagnosis and treatment of chikungunya fever. Part 2 - treatment. Rev Bras Reumatol Engl Ed. 2017;57(Suppl 2):438–451.
  • Brito CA, Sohsten AK, Leitao CC, et al. Pharmacologic management of pain in patients with Chikungunya: a guideline. Rev Soc Bras Med Trop. 2016 Nov–Dec;49(6):668–679.
  • Savarino A, Boelaert JR, Cassone A, et al. Effects of chloroquine on viral infections: an old drug against today’s diseases? Lancet Infect Dis. 2003;3:722–727.
  • Wozniacka A, Lesiak A, Narbutt J, et al. Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus. 2006;15:268–275.
  • Briolant S, Gavin D, Scaramozzino N, et al. In vitro inhibition of Chikungunya and Semiliki forest viruses replication by antiviral compounds: synergistic effect of interferon alfa and ribavirin combination. Antiviral Res. 2004;61(2):111–117.
  • Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J. 1983;63:313–315.
  • Fourie ED, Morrison JG. Rheumatoid arthritic syndrome after Chikungunya fever. S Afr Med J. 1979;56:130–132.
  • Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137.
  • Borgherini G, Poubeau P, Jossaume A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008 Aug 15;47(4):469–475.
  • Feldstein LR, Rowhani-Rahbar A, Staples JE, et al. Persistent arthralgia associated with chikungunya virus outbreak, US virgin Islands, December 2014-February 2016. Emerg Infect Dis. 2017 Apr;23(4):673–676.
  • Lane HC, Marston HD, Fauci AS. Conducting clinical trials in outbreak settings: points to consider. Clin Trials. 2016 Feb;13(1):92–95.
  • Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. Jama. 2015 Apr 28;313(16):1619–1620.
  • Saville BR, Berry SM. Efficiencies of platform clinical trials: A vision of the future. Clin Trials. 2016 Jun;13(3):358–366.
  • Powers AM. Vaccine and Therapeutic Options To Control Chikungunya Virus. Clin Microbiol Rev. 2018 Jan;31(1). pii: e00104–16. doi: 10.1128/CMR.00104-16.
  • Ganesan VK, Duan B, Reid SP. Chikungunya virus: pathophysiology, mechanism, and modeling. Viruses. 2017 Dec 1;9(12):368.
  • Couderc T, Lecuit M. Focus on Chikungunya pathophysiology in human and animal models. Microbes Infect. 2009 Dec;11(14–15):1197–1205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.